Loading clinical trials...
Loading clinical trials...
Novel, non-vitamin K antagonist oral anticoagulants (NOAC) target selected players in the coagulation cascade as the direct thrombin inhibitor dabigatran and the factor Xa-inhibitors apixaban and riva...
Keep your clinical trial research organized — questions to ask, what to expect, and key details.
Lead Sponsor
University Hospital, Basel, Switzerland
Collaborators
NCT07458815 · Intracerebral Hemorrhage
NCT07246473 · Intracerebral Hemorrhage
NCT07458880 · Intracerebral Hemorrhage
NCT07455201 · Intracerebral Hemorrhage
NCT06725108 · Traumatic Brain Injury (TBI), Intracerebral Hemorrhage
Stroke Center, University Hospital Basel
Basel
Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.
Start free trial →Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions